Merck Insider Buying Shows Confidence in Strong Commercial & Vaccine Strategy
Merck insider buying signals confidence in its robust commercial strategy, diversified vaccine and oncology pipeline, and strong market‑access initiatives, offering investors a compelling case for future earnings growth.
4 minutes to read